Scientists attack spreading lung cancer with Immune-Boosting blitz

NCT ID NCT03965468

Summary

This trial is testing if a powerful combination of immunotherapy, chemotherapy, and precise radiation can control advanced lung cancer that has spread to only a few other body sites. The goal is to stop the cancer from progressing further and improve survival. About 96 patients with newly diagnosed, stage 4 non-small cell lung cancer will receive all three treatments, followed by surgery or more radiation to the main lung tumor if the cancer responds.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Hospitalier Universitaire Vaudois (CHUV)

    Lausanne, Switzerland

  • Erasmus Medical Centre

    Rotterdam, Netherlands

  • European Institute of Oncology

    Milan, Italy

  • Geneva University Hospital

    Geneva, Switzerland

  • Hosp. De la Santa Creu i Sant Pau

    Barcelona, Spain

  • Hosp. Sanchinarro- Centro Integral Oncología Clara Campal

    Madrid, Spain

  • Hosp. Uni. Politécnico La Fe

    Valencia, Spain

  • Hosp. Uni. Virgen de las Nieves

    Granada, Spain

  • IRCCS Istituto Nazionale Tumori Regina Elena

    Roma, Italy

  • Inselspital Bern

    Bern, Switzerland

  • Istituto Oncologico Veneto - Irccs

    Padua, Italy

  • Kantonsspital Winterthur

    Winterthur, Switzerland

  • Maastricht University Medical Center

    Maastricht, Netherlands

  • University Hospital Zurich

    Zurich, Switzerland

  • Vall d'Hebron University Hospital

    Madrid, Spain

Conditions

Explore the condition pages connected to this study.